ECT2 and neoplasm: To further investigate whether GEF-independent activity of ECT2 contributes to breast tumor growth, MDA-MB-468 cells stably expressing ECT2 shRNA and ECT2/wt or ECT2/GEFmt were created, and the tumor formation of these cells were examined via xenograft model.